Tandem Diabetes Care (TNDM) 2024年CSR報告「NASDAQ」.pdf

《Tandem Diabetes Care (TNDM) 2024年CSR報告「NASDAQ」.pdf》由會員分享，可在線閱讀，更多相關《Tandem Diabetes Care (TNDM) 2024年CSR報告「NASDAQ」.pdf（76頁珍藏版）》請在三個皮匠報告上搜索。

1、2024SustainableBusiness ReportMichaeldiagnosed 1972For Fiscal Year 2023Table of ContentsIntroduction .4Impact Through Innovation .16Our People&Communities .30Operating Responsibly.62Appendix.704 2024 Sustainable Business ReportAt Tandem Diabetes Care,our purpose is to create new possibilities for pe

2、ople living with diabetes.Our success isnt just measured by our growing number of customers,but how we achieve our goals.We strive to advance environmental,social,and governance(ESG)initiatives throughout our business.By doing so,we are working to make a positive impact on the lives of people with d

3、iabetes,as well as our communities and planet.Tandem Diabetes Care 5Our company name,Tandem Diabetes Care,was chosen with in-tention.We wanted to be“in tandem”with the patients we serve.The word“care”was also purposeful,as our eff orts transcend medical device development and manufacturing with a de

4、eper mission to improve the lives of people with diabetes through relentless innovation and revolutionary customer experience.Our commitment to this mission has made us the#1 recommend-ed pump brand four years and counting by endocrinologists and diabetes educators.1 We also off er the#1 rated autom

5、ated insulin delivery system2 and are#1 in overall satisfaction by U.S.health-care providers.1 Our mission-driven commitment is also refl ected in our annual employee survey,which refl ects 90%participation over the past three years,and the results show world-class engagement and connection to our p

6、urpose.Our success isnt just measured by our high rankings and grow-ing number of customers,but how we achieve our goals.We continue to strive in advancing ESG initiatives throughout our business.By doing so,we are working to make a positive impact on the lives of people with diabetes,but also our c

7、ommunities and planet.For example,in Spring 2023,we moved our corpo-rate headquarters to a building that is Energy Star certifi ed and certifi ed under the U.S.Green Building Councils Leadership in Energy and Environmental Design(LEED).Energy use and environ-mental impact were key factors in selecti

8、ng our new facility.And,as youll see in this report,we are already seeing more effi cient energy use and reduced consumption of resources.While still early in our ESG journey,we remain purposeful in our approach.Weve engaged an experienced third-party advisor to help develop our initial global green

9、house gas(GHG)emissions inventory and develop a GHG inventory management plan.These important steps are helping to prepare us for future climate-related disclosures.Last year,we published our inaugural Sustainable Business Report to lay the foundation for our reporting.We continue to seek opportunit

10、ies to enhance our sustainability eff orts throughout the organization and to provide greater insight into these initiatives.The four principles of the International Financial Reporting Standards(IFRS)help to align our eff orts as we focus our disclosure opportunities on clarity,relevance,reliabilit

11、y,and comparability.As an innovation company,the greatest impact we have on the world,and on our global customers,is through our diabetes care technology,while we also work to minimize our environmental footprint.In many ways,our eff orts in 2023 focused on building and preparing for the future as w

12、e executed on multiple strate-gic initiatives.Most notably was the unprecedented accomplish-ment of being in various stages of launching four new products in the United States,including our new pump platform,Tandem Mobi.The success of our company would not be possible without our people.I am gratefu

13、l for the company,and our family of em-ployees,business partners,and stakeholders who help live out our purpose every day.Our performance and the sustainability progress outlined in this report are testaments to their commit-ment to our mission,our inclusive culture,and our customers.John F.Sheridan

14、1.Seagrove Partners 2023 HCP Perspectives Report,N=265.2.dQ&A US Patient Panel Q3 2023(July-Sept.2023)6 2024 Sustainable Business ReportCorporate Headquarters 12400 High Bluff Drive San Diego,CA 92130(858)366-6900 AboutTandem Diabetes Care,Inc.(NASDAQ:TNDM)is a global insulin delivery and diabetes t

15、echnology company that manufactures and sells advan ced automated insulin delivery systems that reduce the burden of diabetes management.Diabetes management can vary greatly from person to person based on clinical needs and personal preferences.Our goal is to develop insulin pump technology with a c

16、onsumer-focused approach by providing a portfolio of delivery devices,soft ware,and data insight solutions to people living with diabetes,as well as their caregivers and healthcare providers.LocationsTandem Diabetes Care is headquartered in San Diego,California with additional facilities to support

17、our research and development,corporate administration,and manufacturing and warehousing operations.We also maintain offi ces in Irvine,California;Markham,Ontario,Canada;and Saint-Sulpice,Switzerland.Tandem Diabetes Care 7Tandem Offi cesIn 2023,we sold the t:slim X2 insulin pump in the following coun

18、tries:+Australia +Bahamas +Belgium +Canada +Czech Republic +Denmark +Finland +France +Germany +Ireland +Israel +Italy +Luxembourg +Netherlands +New Zealand +Norway +Portugal +Saudi Arabia +Slovakia +South Africa +Spain +Sweden +Switzerland +United Kingdom +United States 8 2024 Sustainable Business R

19、eportOur Promise Partnering to deliver better outcomes through human-centered design and a connected care experience.Olivediagnosed 2014Ilianidiagnosed 2001Tandem Diabetes Care 9Our deep empathy for the daily lived experience of people living with diabetes drives how we design our technology and sol

20、utions.We emphasize safety,ease of use,and consider how each component of the Tandem experience comes together to support the management and care of diabetes.We know that diabetes management is a personal journey to keep blood glucose levels balanced throughout the day and night.Enabled by the right

21、 data and tools,people living with diabetes,and those supporting them,can continually reduce the burden that diabetes has on their daily lives.Partnering to Deliver Better Outcomes Human-Centered Design We are more than an insulin pump company.Wesupport people living with diabetes and their healthca

22、re providers through a forward-thinking approach that brings together science,analytics,customer care,and cutting-edge technology.Connected Care Experience 10 2024 Sustainable Business ReportESG EngagementOur Board of Directors and management team believe that environmental stewardship,social respon

23、sibility,and solid corporate governance are important to our business strategy and create long-term value for our shareholders,employees,customers,and communities.The Nominating and Corporate Governance(N&CG)Committee of our Board oversees ESG matters across our business operations in accordance wit

24、h its charter.Our management team is responsible for developing and driving strategic ESG initiatives and programs across our business and providing regular updates on progress to the Nominating and Corporate Governance Committee.Tandem Diabetes Care 11To achieve our vision,our business and ESG eff

25、orts are synergistic creating long-term value for business stakeholders,while positively impacting the global community through relentless innovation and revolutionary customer care.Market research is a foundational pillar of our company.We started by asking people living with diabetes what they wan

26、t and need in insulin therapy management technology and expanded this by asking the same questions to caregivers,healthcare providers,and payers.Aft er commercializing the t:slim pump in 2012,we began regularly engaging with our customers through surveys and product trainings.In recent years weve ex

27、panded these eff orts to our employees and stockholders through annual engagement and pulse surveys.This helps shape our governance and practices in ways that refl ect our shared values and priorities.Weve focused on enhancing our supplier relationships to better understand the role we play in a cir

28、cular economy.We aim to strengthen our bond and communication in the diverse communities where our employees live and work.Additionally,we support organizations that share our mission to improve the lives of people with diabetes.Our StakeholdersPayers and Healthcare Systems SuppliersShareholdersComm

29、unitiesEmployees CaregiversPeople Living with DiabetesHealthcare Providers 12 2024 Sustainable Business ReportGovernance&Ethics Tandem strives for total customer satisfaction by meeting the quality expectations of our customers;providing excellent leadership,management resources,training and support

30、 for our employees;complying with and maintaining an eff ective quality management system;and providing continual improvement in all processes throughout our organization.EthicsWe have detailed ethics and compliance policies that instill a commitment to ethical behavior and legal compliance across o

31、ur company.Employees are encouraged to approach their managers,or a member of the compliance team,if they believe violations of standards or policies have occurred.Employees are also able to make confi dential and anonymous reports using an online portal or telephone hotline hosted by a third-party

32、provider.We have a code of business conduct and ethics that applies to all of our directors and employees,which we refer to as the Code of Ethics.This Code of Ethics for Directors and Employees,along with an additional Code of Ethics for Senior Financial Offi cers,are available on our website at und

33、er the Investor Center section.Corporate GovernanceWe will continue to reinforce our commitment to ethical governance throughout our organization,while maintaining operational excellence.To aid corporate operations and oversight,we believe that corporate governance should be built on a strong founda

34、tion set by its Board of Directors in conjunction with supporting committees.In its risk oversight role,our Board has responsibility for ensuring that the risk management processes designed and implemented by management are adequate and functioning as designed.In November 2023,our Board of Directors

35、 adopted a Corporate Governance Policy to summarize and provide insight to our governing practices at Tandem.This Policy speaks to Board composition and selection,introduces newly defi ned limitations that Board members may serve on no more than two other public company Boards of Directors,andthe CE

36、O may serve on no more than one other public companys Board of Directors.The role of our Board of Directors in overseeing the manage-ment of our risks is realized primarily through committees,including the Audit Committee,Compensation Committee,Nominating and Corporate Governance Committee,and its C

37、ybersecurity and Data Privacy Oversight subcommittee.Tandem Diabetes Care 13Our governance policies and practices help us appropriately manage risk and live out our corporate values in an ethical,responsible,and sustainable way.Our focus on continual improvement is prevalent throughout our business,

38、which is evidenced in our key recent governance eff orts.Rolling declassifi cation implemented to eliminate our classifi ed board structure Adoption of a Corporate Governance PolicyOur directors have diverse backgrounds with experience in key applicable areas of our business,including corporate stra

39、tegy,digital technology and innovation,global expansion,market access,health economics and outcomes research,data sciences,medical device executive leadership,consum-er technology,data privacy and cybersecurity,and fi nance.Eight of our 10 directors are independent,and all committees are served by i

40、ndependent directors.Since 2020,our Board has made a concentrated eff ort to expand its gender and ethnic diversity,bringing new and diff erent perspectives that better refl ect our mission to support the diverse needs of the diabetes community.As of December 31,2023,our Board of Di-rectors consiste

41、d of three female members and two members who identify with an underrepresented ethnic community.Continued on next page.Recent Governance Enhancements Cybersecurity and Data Privacy Oversight subcommittee establishedPeyton Howell,an independent member of the Board,appointed chair of the Compensation

42、 Committee Updated stock ownership guidelines Rebecca Robertson,an independent member of the Board,appointed Chair of Board of Directors202220232022202320222023JANMARFEBJUNMAYNOV14 2024 Sustainable Business Report14 2024 Sustainable Business ReportGovernance&Ethics continued.Nominating and Corporate

43、 Governance CommitteeOur N&CG reviews our ESG performance and reporting andmaintains oversight of our risks at the highest level.The N&CG is committed to the continuing education of our Board of Directors on evolving ESG topics that are important to ourbusiness.In 2023,our N&CG Committee arranged fo

44、r two ESG-related training sessions,which were attended by the full Board of Directors.The fi rst training session focused on environmental matters and was led by a third-party advisory team.The next training session focused on global environmental landscape,existing and upcoming reporting laws,and

45、the Companys governance around climate-related risks and opportunities.Both sessions were led by third-party experts.Compliance&Information SecurityOur comprehensive cyber-security program is built around a robust risk management framework that adheres to international standards for cybersecurity.Ta

46、ndem Diabetes Care 15Through our Secure Development Lifecycle(SDL),we ensure that security is an integral part of medical device development,from inception to deployment.This approach,coupled with our data protection practices,underscores our commitment to safeguarding patient data and the integrity

47、 of our products against cyber threats.Our proactive stance on cybersecurity extends beyond technical measures to include a strong focus on employee training and stakeholder collaboration.By educating our workforce on best practices and emerging threats,we fortify our fi rst line of defense.Furtherm

48、ore,our engagement with healthcare providers,regulatory bodies,and industry groups enhances our cybersecurity posture and keeps us abreast of the evolving threat landscape.This collective eff ort is crucial for advancing safe medical device development andfostering a secure healthcare technology eco

49、system.The governance structure of our cybersecurity program is designed to facilitate informed decision making and ensure adherence to applicable laws and standards,embodying our commitment to responsible corporate governance.We annually engage with external auditors for a comprehensive review of o

50、ur cybersecurity measures and invite third-party experts to perform penetration tests on our critical systems and products.Moreover,cybersecurity management maintains a direct line to our Board,providing quarterly updates on cybersecurity risks.These initiatives are integral to sustaining the trust

51、of our patients,partners,and investors,and they solidify our reputation as a leader in creating secure,reliable healthcare solutions.16 2024 Sustainable Business ReportImpact Through Innovation We have a focused eff ort on understanding the environmental impact of our business,including the direct i

52、mpact as an employer and manufacturer,as well as the impact on people using the products we off er.Tandem Diabetes Care 17Emmadiagnosed 2008Karadiagnosed 199918 2024 Sustainable Business ReportImpact Through Innovation18181818 8 8 8 8 8 8 8 8 8 8 8 8 818 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2024024

53、0 0 40 0 024 SuSuSuSu uSuS SuSu u u u u u u u u uSuS s s statatatastatata a astas as as s s s as s s sts atas as a ainainainainainanainai inainanain na ainainanin ninana ananainananinaina ainan b b bleblebleb b b b bleble eb ble eb blele ele e e eb e eb e eb e eb e eb b ble e eb bB B B BuB B B B B B

54、 B B B B B B B BuB B B B B B B B B B B B sinsinessess ReReporporpt t*38%smaller than MiniMed 780G.Data on fi le,Tandem Diabetes Care.Bolus delivery from the t:connect mobile app requires a compatible smartphone model and operating system,an app update,a remote soft ware update on the t:slim X2 insul

55、in pump and additional training.Only available to customers who reside in the U.S.Our mobile apps require a compatible smartphone model and operating system(soldseparately).Only available to pump users who reside in the U.S.Our Solutionst:slim X2 Insulin PumpTrue to its name,the t:slim X2 insulin pu

56、mp is up to 38%smaller than other leading insulin pumps,*yet still holds up to 300 units of insulin.Other key features include a color touchscreen,CGM integration with multiple sensors,Control-IQ advanced hybrid closed-loop technology for automated insulin dosing,rechargeable battery,Bluetooth conne

57、ctivity for communicating with multiple external devices simultaneously,and mobile control of select insulin delivery.Tandem Mobi SystemIn 2023,we received FDA clearance for the Tandem Mobi system.Tandem Mobi is approximately half the size of our t:slim X2 pump and is designed for people who seek ev

58、en greater discretion and fl exibility with the use of their insulin pump.Its features include full pump control from our mobile application,a 200-unit cartridge,a Pump button,and inductive charging.It uses the Control-IQ advanced hybrid closed-loop technology predictive algorithm.Tandem Diabetes Ca

59、re 19disposable batteries will be kept out of landfi lls during these customers 4-year pump warranty44 million Key Environmental Design Features The environmental impact of consum-er use of our product off erings is also a focus for our company.This starts with innovation in our product design.Estim

60、ation since Aug.31,2012,as of Dec.31,2023,assuming 20-day battery life of disposable batteries when used in other insulin pumps,and updated to refl ect$12.99 for 4-pack of lithium Energizer batteries.Data on fi le at Tandem Diabetes Care.Rechargeable BatteryOur t:slim X2 and Tandem Mobi insulin pump

61、s use rechar-geable batteries,eliminating the need to use alkaline batter-ies.Each Earth Day we report on estimated batteries saved since our pumps became available in 2012.We estimate that:of saved battery expenses$143 million 1=of saved battery expensesdisposable batteries have been kept out of la

62、ndfi lls by our customers27 million$89 million=20 2024 Sustainable Business ReportImpact Through Innovation20 2024 Sustainable Business ReportSoft ware Updatable via Tandem Device UpdaterOur durable insulin pumps are unique because our users can update soft ware quickly and easily from a personal co

63、mputer.*Historically,insulin pump upgrade programs had required a physical exchange of hardware.Yet,through the Tandem Device Updater,more than.Fewer replacements of screens,circuit boards,and batteries soft ware updates have been performed380,000 2Key Environmental Design Features continued.fewer U

64、PS shipments760,000=*Future updates for all or some Tandem products may not be developed and may not be off ered everywhere and would be subject to applicable regulatory approvals.Soft ware updates are only available to customers who are in warran-ty at the time they update their pump.Additional tra

65、ining may be required to access certain soft ware updates.Charges may apply.Tandem may discontinue select soft ware and features over time at its discretion.Tandem Diabetes Care 21pumps were refurbished in 2023 55,000Lean Principles Tandem continues to achieve operational excellence through the use

66、of lean princi-ples an ongoing company practice that defi nes the way we approach and act on our operations.We use this process,among other eff orts,to continually identify and eliminate waste where possible.Refurbishment Program We have a refurbishment program that allows for the reuse of key compo

67、-nents,thereby reducing electronic waste.weight reduction for new cartridge shipping pallets20%Packaging Reduction 2023 marked the fi rst full year of Tandem using a new,recyclable cartridge packaging material that reduced packaging material weight by 45%.22 2024 Sustainable Business ReportImpact Th

68、rough InnovationControl-IQ TechnologyControl-IQ advanced hybrid closed-loop technology is an automated insulin dosing feature that is designed to help increase a users time in targeted glycemic range(70-180 mg/dL).It has been featured three times in the New England Journal of Medicine,is used by the

69、 majority of our customers worldwide,and off ers both immediate and sustained clinical benefi ts to help ensure healthy lives across diverse populations.The t:slimX2 insulin pump with Control-IQ technology was the fi rst automated insulin delivery(AID)system cleared by the FDA to deliver automatic c

70、orrection boluses*in addition to adjusting basal insulin to help prevent high and low blood sugar.Control-IQ technology off ers optional settings for Exercise Activity and Sleep Activity that adjust the algorithm parameters to better match the diff erent physiological needs during these activities.A

71、ctivity SettingsTandem Diabetes Care 23Independent studies show the eff ectiveness of Control-IQ technology including pub-lication in the New England Journal of Medicine.*If glucose values are predicted to be above 180 mg/dL,Control-IQ technology calculates a correction bolus using the Personal Prof

72、i le settings and a target of 110 mg/dL and delivers 60%of that value.1.Brown SA,Kovatchev BP,Raghinaru D,et al.Six-month randomized,multicenter trial of closed-loop control in type 1 diabetes.NEngl J Med.2019;381(18):1701-1717.doi:10.1056/NEJMoa1907863.2.Kudva YC,Laff el LM,Brown SA,et al.Patient-R

73、eported Outcomes in a Randomized Trial of Closed-Loop Control:The Pivotal International Diabetes Closed-Loop Trial.Diabetes Technol Ther.2021;23(10):673-683.doi:10.1089/dia.2021.0089 3.Breton MD,Kovatchev BP.One year real-world use of the Control-IQ advanced hybrid closed-loop technology.Diabetes Te

74、chnol Ther.2021;23(9):601-608.doi:10.1089/dia.2021.0097.Time Spent in Closed LoopAverage time Control-IQ technology study participants spent in closed loop over a six-month period.1Said it was Easy to UsePercent of Control-IQ technology participants said the algorithm on the t:slim X2 pump was easy

75、to use.2 Time in RangeAverage time in range per day for real-world users of Control-IQ technology compared to 64%prior to Control-IQ technology use.3749794%24 2024 Sustainable Business ReportImpact Through InnovationDigital Health PlatformsOur goal is to drive innovation across our digital health pl

76、atforms by responsibly using the vast amounts of data that we collect.We intend to use cutting-edge technology,such as artifi cial intelligence and machine learning,to provide information and insights to people living with diabetes,their caregivers,healthcare providers,and insurance payers.Our key o

77、bjectives include making these insights easy to understand,off ering the data in real time,and providing the information in a fl exible format with mobile or web apps.In addition,we are working to integrate health-related information from third-party sources and using our data to support current and

78、 future products under development.Tandem SourceThis platform provides users,their caregivers,and their healthcare providers with a fast,easy,and visual way to display diabetes therapy man-agement data from our pumps,integrated CGMs,and supported blood glucose meters.We have amassed more than half a

79、 million patient years of data from t:slimX2 pump users in the U.S.11.As of April,2024.Data on fi le,Tandem Diabetes Care.Tandem Diabetes Care 25Mobile AppsOur mobile apps provide Tandem pump users with convenient and discreet data display and alerts.*In 2022,we received FDA clearance for a mobile b

80、olus feature that allows t:slim X2 pump users to control a bolus of insulin through our mobile app using their personal smartphone.It is the fi rst-ever FDA-cleared smartphone application capable of initiating insulin delivery on both iOS and Android operating systems.The Tandem Mobi mobile app allo

81、ws users to control their Tandem Mobi system from their personal,compatible iPhone.downloads of the mobile app by the end of 2023380,000*Uploads to Tandem Source do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring.Standard

82、carrier data rates may apply.26 2024 Sustainable Business ReportImpact Through InnovationFuture Innovations t:slim X3 Insulin PumpAdvancing our fl agship t:slim platform,the t:slim X3 is planned to include enhanced technology,such as greater processing power and capacity to support our advanced algo

83、rithms,as well as increased battery life and improved durability.Sigi Patch PumpThe ergonomic,rechargeable Sigi pump is intended to reduce the burden of managing diabetes through its use of pre-fi lled insulin cartridges and compatibility with AID technology.Tandem Mobi:TubelessThis off ering is int

84、ended to provide an alternative tubeless infusion site option for Tandem Mobi pump users.It will allow a Tandem Mobi pump to be worn completely on the users body with no tubing.A goal of this design is to allow people living with diabetes to customize the way they wear their pump with each cartridge

85、 change,switching between tubed and tubeless wear confi gurations,to best suit their personal preferences and lifestyle.We continue to use innovative techniques to reduce environmental impact and deliver products that can change lives.Tandem Diabetes Care 27Control-IQ Technology AdvancementsWe are c

86、ontinuing to drive innovation in our algorithms by emphasizing automation,personalization,and simplifi cation to continue to improve therapeutic outcomes and provide a positive patient experience.In 2023,we began a pivotal study to support expanding indications to include people living with type 2 d

87、iabetes.In late 2023,our Control-IQ technology was cleared with additional features for people with type 1 diabetes age 2 and older.We are also researching the use of diff erent insulins with our Control-IQ technology.Extended Wear Infusion SetsInfusion sets provide additional choice and fl exibilit

88、y to people living with diabetes.Our goals for infusion set innovations focus on solutions that extend wear time and enhance user experience,while reducing occlusions,body burden,and waste.In support of this eff ort,unique extended wear infusion set technology is expected to be part of our future po

89、rtfolio.28 2024 Sustainable Business ReportImpact Through InnovationHuman-Centered Design We develop our insulin pump technologies and related products and services with a human-centered approach.Our ongoing application of behavioral sciences enables an understanding of what people with insulin-depe

90、ndent diabetes,their caregivers and healthcare providers need and want from their diabetes technology.We then look to modern consumer technology for inspiration and develop our hardware and soft ware solutions.This approach has resulted in solutions that provide customers with useful,usable,and mean

91、ingful experiences with Tandem.Human-centered design is a data-informed approach to design and development that is grounded in individuals lived experience over time.Ours is an evidence-and principles-based practice aimed at bringing the benefi ts of automated insulin delivery to more people around

92、the world.Our guiding principles include:Enable users to make data-informed decisions,but doesnt require users to be data-driven Respect that humans attentional resources are fi niteDesign in consideration of daily life,which varies between and within individuals over time Design for behavior plus u

93、nmet needs Burden the system,not the user Tandem Diabetes Care 29Improving Representation inResearch Studies Tandem is committed to serving individuals of all backgrounds who live with diabetes.We are aligning our clinical trial eff orts with the FDA Draft Guidance,“Diversity Plans to Improve Enroll

94、ment of Participants from Underrepresented Racial and Ethnic Pop ulations in Clinical Trials Guidance for Industry.”In 2022,we included our fi rst Race and Ethnicity Diversity Plan in a pivotal study application to FDA.This plan supports improved eff orts to enroll and retain participants in our piv

95、otal trial for type 2 diabetes,with updated training materials and enrollment goals that will allow us to generalize our results to the broader population at large.In the plan,we highlighted specifi c aspects of the trial designed to enroll and retain minority populations,as well as including a dive

96、rse user base for evaluating our technology with participants of varied age,insulin use,and adjuvant medications.This example is part of an ongoing eff ort to ensure that Tandem studies refl ect the diversity of the diabetes community and will help empower us to create products that can eff ectively

97、 serve their needs.Research Study Recruitment Strategies and Platform In partnership with Thrivable Insights,a research agency,we continue to bridge the gap between medical device companies and underserved communities.Each person with diabetes who volunteers to join Thrivables database is eligible t

98、o participate in all kinds of diabetes research,not just specifi c to Tandem.Additionally,we continue to liaise with community advocacy groups such as the Accessible Insulin Task Force(AITF)to increase diversity of participant groups.30 2024 Sustainable Business ReportOur People&Communities Because

99、we work alongside colleagues who are living with diabetes,our mission is personal.That connection helps fuel our passion and drives our commitment to serving the diabetes community.Tandem Diabetes Care 31Brittneydiagnosed 2008Hudsonhelping since 201632 2024 Sustainable Business ReportOur People&Comm

100、unities Approximately seven million people use intensive insulin therapy in the areas weserve.Our Customers Since launching our t:slim insulin pump in 2012,we have trans-formed our company from a domestic,venture-backed insulin pump start-up to a self-sustaining,global diabetes technol-ogy company.A

101、s a result,we have meaningfully contributed to expanding the global insulin pump market to more than 1.3million pumpers worldwide.More than 800,000 people use pump technology in the United States and in the countries we serve,about 500,000 people use pump technology outside of the United States.Our

102、technology solutions are now available in 25countries worldwide and we are proud to have more than 450,000Tandem pumps currently in the market.More than 90%of our customers have type 1 diabetesNolandiagnosed 2017Wide age distributionEqual mix of women and menTandem Diabetes Care 33Mauradiagnosed 197

103、8A Large and Growing Worldwide MarketDiabetes is a chronic,life-threatening disease for which there is no known cure.It touches people of diff erent ages,races,and genders around the world.We consid-er our addressable market to be people diagnosed with diabetes who are living with either type 1 diab

104、etes or with type 2 diabetes who require intensive insulin therapy.In the geographies we serve,we estimate fi ve million people live with type 1 diabe-tes,of whom,1.9 million reside in the United States.We estimate two million people in the United States live with type 2 diabetes who require intensi

105、ve insulin therapy.In-Warranty Customer Installed BaseEstimate based on rolling 4-year U.S.()and international()shipments.300,000350,000400,000250,000200,000150,000100,00050,00020182019202020212022202334 2024 Sustainable Business ReportOur People&Communities Committed to Customer Satisfaction We are

106、 committed to providing our customers with a positively diff erent experience.What enables us to do this is understanding what customers expect from our brand and how best to meet their needs.Throughout their journey with us,we seek feedback through surveys,focus groups,and training to understand op

107、portunities for continual improvement.We measure customer satisfaction in the U.S.through automated survey feedback across key time points within the customer journey,including sales support,training,technical support,and ongoing product use.In 2019,we began implementing new technology to automate t

108、he process for real-time feedback.This steady stream of customer insight enables company leaders to make business changes or improvements as needed.In 2023,we achieved our targeted metric for customer satisfaction in our short-term incentive compensation plan,and this component is included again in

109、our plan for 2024.Terancediagnosed 2008Net Promoter Score(NPS)77Our 2023 average NPS is a refl ection of our brand loyalty and was the highest rating among integrated system insulin pumps.1Tandem Diabetes Care 35Purchasing Process and Financial Assistance Insulin pump therapy is an investment in you

110、r health.In the U.S.,our insulin pumps and supplies are typically reimbursed through a customers Durable Medical Equipment insurance benefi t.Aft er a new customer fi lls out a form to start the process of getting a t:slim X2 pump or a Tandem Mobi system,a Tandem representative reaches out to the cu

111、stomers healthcare provider and insurance company(s)to help determine their benefi ts and communicates them to the customer.In 2022,we launched an expanded Flexible Payment Plan in the U.S.so cost would not be a barrier for people adopting our technology.This plan is designed to provide customers wi

112、th the option of making monthly payments to spread their pump or supply costs over an extended period of up to 48 months.In 2023,we began developing the Tandem Charity Care Program,which is an expanded fi nancial assistance program.This program is designed to help mitigate fi nancial barriers to acc

113、essing Tandems products for eligible customers regardless of the customers age,disability,gender,race,religious affi liation,immigration status,sexual orientation,national origin,and whether or not the customer has health insurance coverage.Weplan to launch this program in 2024.1.dQ&A U.S.Patient Pa

114、nel,Q1 2023 and Q3 202336 2024 Sustainable Business ReportOur People&Communities In 2022,it was estimated that one out of every four U.S.healthcare dollars went towards diabetes.1 At Tandem Diabetes Care,we look to improve the cost of diabetes care by improving clinical outcomes and reducing insulin

115、-related adverse events.Our Market Access eff orts focus on navigating the complexities of healthcare reimbursement systems,payer policies,and regulatory requirements.To achieve this,we engage with payers and channel partners to ensure people living with diabetes can access the Tandem portfolio of p

116、roducts effi ciently,expeditiously,and in the most cost-eff ective manner.Our investment in Health Economics and Outcomes Research(HEOR)seeks to generate evidence that demonstrates value to payers,providers,and the people living with diabetes to whom we serve.We aim to demonstrate the value of the T

117、an-dem portfolio of products from an economic,clinical,and pa-tient perspective using robust research methodologies that incorporate real-world data and health economic modeling.In 2023,we presented data at the 83rd American Diabetes Association Scientifi c Sessions demonstrating that Control-IQ tec

118、hnology use improved HEDIS A1c(GMI)outcomes across all payer types,with the largest glycemic improvement seen in those with the highest A1c at baseline and for prior MDI One-third of insulin-treated adult patients do not reach ADA recommended goal of A1c below 7.0%.246%of adults with diabetes mellit

119、us treated with insulin experienced insulin-related hypoglycemia and errors lead-ing to emergency room visits.3Continued on next page.Tandem Diabetes Care 371.Parker ED,et al.Economic Costs of Diabetes in the U.S.in 2022.Diabetes Care.2024;47(1):26-43.doi:10.2337/dci23-0085.2.Blonde L,Brunton SA,Cha

120、va P,et al.Achievement of Target A1C 7.0%(53mmol/mol)by U.S.Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.Diabetes Spectr.2019;32(2):93103.doi:10.2337/ds17-0082.3.Shehab N,Lovegrove MC,Geller AI,et al.US Emergency Department Visits for

121、 Outpatient Adverse Drug Events,2013-2014 JAMA.2016;316(20):2115-2125.doi:10.1001/jama.2016.16201.Diabetes doesnt rule my life.Control-IQ technology can help handle a lot of it for me.It has a brain.Its like wearing a pancreas.It helps you so you dont have to think about your diabetes as much.Angied

122、iagnosed 199438 2024 Sustainable Business ReportOur People&Communities Purchasing Process and Financial Assistance continued.users.In addition,we received a Gold Poster Award at the 2023 Academy of Managed Care Pharmacy annual conference for our data predicting the impact of switching from multiple

123、daily injections to a hybrid closed-loop system on rates of high-cost adverse events for patients with type 1 diabetes.11-point reduction in A1c and a 3-point reduction amongst high-risk individuals*across all payer types.210-44%reduction in high-cost adverse events over fi veyears and 35-81%reducti

124、on amongst high-risk population.3Audrinadiagnosed 2016*High-risk population have A1c of 9%or higher.High-cost adverse events included diabetic ulcers,stroke,CHF,MI and neuropathy.Tandem Diabetes Care 391.Blonde L,Brunton SA,Chava P,et al.Achievement of Target A1C 7.0%(53 mmol/mol)by U.S.Type 2 Diabe

125、tes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.Diabetes Spectr.2019;32(2):93103.doi:10.2337/ds17-0082.2.Patel BV,Alencar G,Wang SM,Leas S,Messer LH,Pinsker JE.HEDIS Glycemic Goals Achieved by Control-IQ Technology Users Across All Payer Types.Diabe

126、tes.2023;72(Supplement_1):154-LB.3.Zur R,Little A,Anaya P,Wang SM,Patel BV,Bilir P.Predicting the impact of switching from multiple daily injections to a hybrid closed loop system on rates of high-cost adverse events for patients with type 1 diabetes.J Manag Care Spec Pharm.2023;29(No.10-a Suppl.):S

127、1-S138.Tandem has taken a signifi cant amount of stress off of my plate.I can still play sports without worrying as much about my blood sugar.Control-IQ technology puts my diabetes on the backburner.This pump is my best friend.I can put it almost anywhere on my body.Its so compact.When I turn over a

128、t night,it turns over with me.It makes me feel healthy.I dont feel like I have a chronic condition.I dont have to worry about waking up low.Idont have to worry about pulling out my pump at the playground with my kids.Tandem means less stopping and more living.Im not avoiding my life.Tristan diagnose

129、d 1997Marian diagnosed 1990Kara diagnosed 1999Positively Impacting Peoples Lives 40 2024 Sustainable Business Report“In the tapestry of corporate responsibility,the threads of inclusion weave a narrative of strength,resilience,and progress.A companys commitment to fostering diverse and inclusive com

130、munities is not just a metric;its the compass guiding us towards a sustainable future where every individual,regardless of background,contributes to the vibrant fabric of success.”Leila Kater,VP,Human ResourcesTandem Diabetes Care 41+Race +Color +National Origin +Ancestry +Religion +Sex +Pregnancy S

131、tatus +Sexual Orientation +Gender Identity orExpression +Marital Status +Age +Physical or MentalDisability +Medical Condition +Genetic Information or Characteristics +Veteran Status We are committed to treating everyone equally without regard for personal characteristics including,but not limited to

132、:EmployeesWe are committed to creating and maintaining a safe,diverse,and inclusive community for all employees while we serve our customers and fulfi ll our mission to improve the lives of people with diabetes.As of December 31,2023,we have approximately 2,400 regular full-time employees,all of who

133、m work in the United States,Canada,or Europe.We believe that a culture of Diversity,Equity,and Inclusion(DEI)enables us to create,develop,and fully leverage the strengths of our workforce to exceed customer expectations and meet our growth objectives.We also believe that fostering a DEI culture begi

134、ns with our management team,and we regard diversity in our workforce as essential to serving our customers and communities as we execute our long-term strategies.4,0003,0002,0001,000201820192020202120222023Full-Time Employee Headcount42 2024 Sustainable Business ReportOur People&Communities Company

135、CultureTandem Diabetes Care holds itself to the highest values of integrity,professionalism,and courtesy.But we also know how to have fun.We dont just say these words,we live by them so that we can create a positively diff erent experience.Team Up How we work as a team is as important as what we del

136、iver.Transparency,honest communication,and partnering to solve problems are critical to our success.We bring people along to ensure were all on the same path and create the space to respectfully challenge ideas.People First Caring for the people who use our pumps is our top priority.We are fi ercely

137、 loyal to them and the entire diabetes commu-nity.This starts with developing a deep understanding of their daily experiences,triumphs,and challenges.When making business decisions,we always ask ourselves and our partners,“How will this impact the people who count on us?”No Shortcuts Making things m

138、ore effi cient and cost eff ective is great!Tak-ing shortcuts is not.Peoples lives depend on us.Our partners trust us.So we hold ourselves to the highest integrity and eth-ical standards and deliver exceptional quality in everything we do.We do what it takes to get it right,and were proud of it.Stay

139、 Awesome We value and embrace every person at Tandem their unique backgrounds,experiences,and perspectives.Here you can do great work and be yourself,fl ip-fl ops and all.Through universal respect and genuine care,we trust one another to do whats best for all of us.Tandem Diabetes Care 43Survey Says

140、In 2021,we began conducting annual employee engagement surveys through Gallup,a leading global consulting fi rm.More than 90%of our employees have participated each year.The results refl ected that we are a mission-driven company,with employees responses towards our strength of purpose far exceeding

141、 Gallups measurement for world class.Our overall engagement levels exceed Gallups averages worldwide,in the United States,and in life sciences.Innovate Every Day We rely on new ideas,and people who keep their minds open to how to make them happen,to deliver products and expe-riences that can change

142、peoples lives.When faced with a revolutionary concept or simply a better way,in any role,we try to say yes(or at least maybe)before we say no.The top three reasons employees say they love working at Tandem are:The People,Teamwork,and Awesome Purpose.44 2024 Sustainable Business ReportOur People&Comm

143、unities Talent AcquisitionHiring and retaining top talent is the primary focus for the Talent Acquisition(TA)team.In support of this goal,the TA team set out in early 2022 to transform the way in which we attract,assess,and make decisions about talent.In 2023,we successfully implemented a structured

144、 hiring framework across the organization that provides hiring managers and interview teams a standardized and inclusive approach to recruitment and assessment,so equitable and data-informed hiring decisions can be made.Additionally in 2023,the TA team remained focused on furthering our mission of a

145、ttracting and hiring top talent by completing the following:+In partnership with DEI,completed an Inclusive Recruiting Fireside Chat series aimed at educating the organization on the benefi ts of astructured hiring framework+Rebranded the Tandem Careers website to include a more robust overview of b

146、enefi ts for U.S.-based employees,more insight into the Tandem commitment to learning and development,and to highlight the work of our DEI Council and expansion of inclusion communities throughout 2023+Established new TA partnerships in support of our goal of attracting and hiring top-tier talent wi

147、th diverse experiences and perspectivesTalent Acquisition PartnersOur TA team partners with a variety of non-profi t organizations to build connections,engage with talent,and establish Tandem as an employer of choice within the market.Additionally,our team is seeking new recruiting tools and resourc

148、es to continue building diversifi ed talent channels.We continue to work closely with several of our partners to support recruiting goals and to empower current employees who participate in the program off erings.In 2023,Tandem Diabetes Care was proud to partner with the following not-for-profi t or

149、ganizations in support of furthering our diversity initiatives:+2U+San Diego Squared(SD2)+Tech San Diego(SD)+AnitaB.org+CodePath+The Honor Foundation+National Foundation for Autism Research(NFAR)+Girls Inc.of San Diego County+Colleges&Universities(USD,SDSU,UCSD)Tandem Diabetes Care 45“Hiring and nur

150、turing top talent is the cornerstone of our ability to innovate.Its not just about fi nding great individ-uals;its about cultivating a team that refl ects the rich tapestry of the com-munities we serve.Our commitment to diversity,equity and inclusion isnt just a checkbox its a fundamental princi-ple

151、 that drives us at Tandem.By actively supporting our partners and maintain-ing deep roots within our communities,we aim to continually position Tandem as a career destination.We achieve this through robust community part-nerships,equitable and inclusive hiring practices,and a culture of continual in

152、novation in how we engage and empower our people.”Gioia Woo,DirectorTalent Acquisition 46 2024 Sustainable Business ReportOur People&Communities Diversity,Equity,and InclusionOur DEI goals focus on cultivating and encouraging an inclusive and equitable culture where diversity of thought is represent

153、ed and can thrive throughout our organization.We believe that a culture of inclusion and diversity enables us to create,develop,and fully leverage the strengths of our workforce to exceed customer expectations and meet our growth objectives.DEI ProgramAt Tandem,people are at the heart of our success

154、.We are dedicated to building a company that mirrors the diversity of the individuals we serve.Achieving this requires a commitment to honesty,authenticity,and continual pursuit of growth,knowledge,and improvement year aft er year.Most importantly,we aim to achieve these goals as a unifi ed communit

155、y.This past year marked continual growth for DEI:+Launched and established four new inclusion communities +Amplifi ed voices from throughout the organization through inclusion events and our DEI Employee Blog+Continued to identify ways to further integrate DEI into our people,products,and business p

156、ractices.Our DEI eff orts are focused on diabetes representation and access,representation in leadership,representation in technology roles,and inclusive practices.We are focused on cultivating our internal culture through diversity of thought,and a commitment to building and maintaining a diverse,i

157、nclusive workforce.We also engage in broader support and advocacy within the diabetes community.Tandem Diabetes Care 47IN Tandem is the foundation on which DEI at Tandem is built.IN Tandem represents unity and the commitment we all have to one another in building and strengthening relationships.It s

158、peaks to all of us working together to make Tandem a place that is welcoming and inclusive of diff erences,knowing that diversity is a driver of innovation.IN Tandem is how we show up each day,how we lead our teams,and how we work to-gether to build safe and creative spaces for everyone.IN Tan-dem m

159、eans we foster an environment that values diff erences and diverse perspectives so we can continue to fully support our mission to improve the lives of people with diabetes.DEI CouncilThe Tandem DEI Council is comprised of employee represen-tatives from diff erent parts of our company and we encoura

160、ge individuals from any part of our business to apply to these roles.Council members are a critical part of the DEI culture,ensuring the voice of the employee is always at the table.As an organization,we rely on the Council to provide feedback on poli-cy creation,revise current practices,and ensure

161、were always keeping people at the center of our decision-making practices.Our DEI VisionWe are continuing to cultivate and encourage an inclusive and equitable culture.Our ability to safely and aff ordably deliver the most eff ective treatments for people living with diabetes relies on the diversity

162、 of our entire team and an equitable workplace that enables all employees to thrive.Our vision is to do this through focusing on:Diversity IN Diabetes:Our goal is to ensure that future Tandem-funded and-led studies better represent the diabetes community that we serve and we remain focused on drivin

163、g equitable access to our products.Representation IN Leadership:Our goal is to cultivate a diverse workforce,representative at all job levels,of the communities we serve.Representation IN Tech:Tandem seeks to encourage diversity by broadening the communities from within which we recruit,engage,and r

164、etain qualifi ed top-tier talent.IN it Together:We strive to continuously improve employee experience and belonging within Tandem by embracing a culture of inclusion.Continued on next page.48 2024 Sustainable Business ReportOur People&Communities Diversity,Equity,and Inclusion continued.Employee Res

165、ource GroupsOur Inclusion Communities Program is our Employee Resource Group initiative and is an integral component of our vibrant corporate culture.Inclusion Communities contribute to a workplace where diversity,collaboration,and support intersect,fostering an environment where every individual ca

166、n thrive both personally and professionally.As we continue to grow and evolve,these communities stand as pillars of our commitment to creating a workplace that values and uplift s every voice.Inclusion Communities were given the name intentionally because they are designed to:+Be inclusive of all em

167、ployees of Tandem,including allies+Encourage crossover and partnership between diff erent communities to honor the multi-faceted nature of everyone at Tandem Diabetes CareSWAGMIT(Supporting Women and Gender Minorities in Tandem)is focused on providing a community of support for women and gender mino

168、rities and their allies.The community focuses on creating a space for employees to work together to empower one another and strive for cultural growth within Tandem Diabetes Care to enable equity and lasting equality.The t:pride community is where everyone,regardless of gender identity or sexual ori

169、entation,are welcome to learn about,engage with,and celebrate the LGBTQIA+community.The group aims to inspire openness by connection and fostering a sense of unity between individuals from the LGBTQIA+community and their allies.The t:green community is focused on environmental sustain-ability.The gr

170、oup is committed to informing and empowering Tandem Diabetes Care employees and leadership to make bold,sustainable choices and championing the environment in both their personal and professional lives.Parents Tandem is focused on connecting parents,guard-ians,and those who regularly care for kids w

171、ith their allies to foster and develop diversity,equity,and inclusion at Tandem Diabetes Care.Their aim is to create a space where commu-nity members can form a support system and sounding board for all that comes with being a working parent or guardian.The Pacifi c Islander and Asian Coalition at T

172、andem(PACT)aims to connect individuals from the Asian American,Native Hawaiian,and Pacifi c Islander(AANHPI)communities with their allies within Tandem Diabetes Care.Parents TandemPACTBETt:greent:prideSWAGMITTeam DiabetesTandem Diabetes Care 49New Employee Resource GroupsWe are thrilled to introduce

173、 two new inclusion communities in 2024,further expanding our commitment to diversity,equity,and inclusion.Black Employees at Tandem(BET)is a community dedicated to celebrating and supporting the unique experiences and contributions of Black employees,fostering a sense of belonging and empowerment.Te

174、am Diabetes is a community that provides a supportive space for employees living with diabetes.By fostering understanding,shared experiences,and promoting well-being,Team Diabetes at Tandem aims to create a network that uplift s and empowers individuals facing similar challenges.LEVELSMaleFemaleNon-

175、BinaryMaleFemaleNon-BinaryExecutives64.3%35.7%0%72.2%27.8%0%White55.6%80.0%69.2%80.0%Ethnic Diversity44.4%20.0%30.8%20.0%Management53.8%46.1%0.1%55.7%43.9%0.3%White63.7%64.6%100%58.8%65.0%66.7%Ethnic Diversity36.3%35.4%41.2%35.0%33.3%Staff 36.0%63.6%0.4%35.3%64.3%0.5%White40.6%43.8%77.8%38.9%42.7%63

176、.6%Ethnic Diversity59.4%56.3%22.2%61.1%57.3%36.4%OVERALL40.6%59.0%0.4%41.4%58.2%0.4%5258%of Ethnic Diversity(US)%of Women GloballyTandem Employee Diversity Summary 2022 2023Note:The Executive level includes Senior Vice President,Executive Vice President,Chief Financial Offi cer,and Chief Executive O

177、ffi cer positions.The Management level includes Supervisor,Prinicpal Engineer,Senior Engineer,Manager,Senior Manager,Associate Director,Director,Senior Director,and Vice President positions.The Staff level includes Individual Contributor and Buyer positions.50 2024 Sustainable Business ReportOur Peo

178、ple&Communities Organizational Development Attracting,developing,and retaining employees is critical to our long-term success.We have established a comprehen-sive training program to develop employees throughout the organization.Emerging Leaders and Leading in Tandem are examples of internal program

179、s intended for high-performing individual contributors,and newly hired and promoted super-visors and managers,respectively.More than 95%of employ-ees participating in these programs remained employed at Tandem as of the end of 2023.Our leadership team also mentors rising talent on a more informal ba

180、sis.This mentorship achieves a number of goals,including accelerating the development of top performers,increasing organizational learning,and improving employee retention.The executive team also commits substantial time to evaluating the bench strength of our leadership and working with our managem

181、ent to improve its performance.participated in our leadership development programs in 2023400employeesTandem Diabetes Care 51Rallying people to thrive and infl uence positive changeAchieving Your Leadership Potential How do I advance my leadership skills?For leaders at the Director level or aboveMas

182、tering leadership competencies to lead self and others,across and up321212121214Leading in TandemHow do I build my skills to lead others?For people leaders new to management roles,either of people,projects,orprograms Developing foun-dational leadership competencies 421212121213Emerging Leaders How d

183、o I lead?For high-potential individual contributors 9-plus months in a role Building foundational leadership skillsIgniting the Leader in You How do I develop as a leader?For individual contributors 3-plus months in role Introducing individu-als to leadership skills 4312 2 2 2 2432 2 2 2 21 1 1 1 15

184、2 2024 Sustainable Business ReportOur People&Communities Training We have comprehensive safety training programs that ensure our employees know how to do their jobs safely and in compliance with laws and regulations.We operate in modern,effi cient,and safe facilities and have had minimal accident an

185、d injury rates company-wide.Despite this success,however,our goal remains the same:Zero accidents.Areas of Safety Training +Personal Safety and Facilities+Ladder,Electrical,Laser,and Lift ing Safety +Ergonomics and Healthy Workplace+Warehouse and Load Dock Safety +Equipment Safety Essentials and Mac

186、hine Guarding +Power Tools,Motorized Pallet Truck,and Handcart Safety Tandem Diabetes Care 53Health and Safety Performance The health and safety of our employees is our highest priority,and this is consistent with our operating philosophy.We have integrated our employee health and safety eff orts wi

187、th our human resources functions to create a corporate culture with a shared commitment to the well-being of our professionals.Key Environmental Health&Safety(EH&S)Initiatives +Required ergonomic training customized for all employees+Fire extinguisher,CPR,and fi rst aid training off ered annually +P

188、eriodic fi re drills,at least annually,at all facilities +Digital chemical management system for safety data sheets +EH&S participation in management meetings to highlight our health and safety programs +Composting in California offi ces +Launching annual E-Waste recycling event for disposal of pers

189、onal electronic waste+Chemical Hygiene Plan,Hazard Communication,Hazardous Waste,and Accidental Release Procedures +Lock Out Tag Out +Emergency Action Plan +Personal Protective Equipment Awareness +Hearing Conservation Program Procedure +Travel Safety+Injury and Illness Prevention Program Procedures

190、 +R&D Safety Training Areas of Compliance Training +Anti-Harassment +Anti-Bribery and Anti-Corruption +Code of Ethics and Insider Trading+Corporate Governance and Fraud Prevention +Compliance Standards +Cybersecurity +Data Privacy Regulations+Federal,State,and Company Policies and Procedures Data202

191、22023TRIR*1.540.83Industry Average TRIR1.4Experience Modification5851Total Reportable Incident Rate(TRIR)*TRIR for 2022 and 2023 includes Covid cases.Based on NAICS code 339112:Surgical and medical instrument manufacturing,2023 data not available until later in the year.The experience rating compare

192、s the experience of Tandem with average employers in the same classifi cation 100 or(1.0)being the average and a rating under that would refl ect better than average experience and result in a premium credit.54 2024 Sustainable Business ReportTotal Rewards Our compensation program is designed to ali

193、gn employee compensation with performance and market-competitive pay,providing the right mix of base pay,bonus opportuni-ty,and equity to attract,retain,and motivate employees to achieve superior results.The structure of our compensation program balances competitive base pay and incentives for both

194、short-and long-term performance.Base pay increases and incentive compensation are based on company performance as well as each individuals contribution to the results and are documented through our talent management process as part of our annual reviews.We provide employees with competitive salaries

195、 that align to job responsibilities,performance,skill levels,experience,knowledge,and geographic location.To foster a strong sense of ownership,restricted stock units are provided to eligible employees under our broad-based stock incentive program.We also off er a competitive employee stock purchase

196、 plan that allows employees to purchase our company stock at a discount.How We Stay CompetitiveWe engage in nationally recognized,external compensation and benefi ts fi rms to independently evaluate the eff ective-ness of our compensation and total rewards programs and Continued on next page.Tandem

197、Diabetes Care 55We Pay for PerformanceMix of diversifi ed long-and short-term performance metrics to incentivize and reward the achievement of our operational and long-term business strategy objectives.Long-term equity incentive awards feature a three-year vesting schedule and have evolved from 100%

198、stock options to include use of restricted stock units.No single-trigger cash severance or automatic vesting of equity awards based solely upon a change of control ofthe Company.We Seek to Mitigate Compensation Risk Annual compensation assessment;retain independent compensation consultant.Clawback p

199、olicy covering both cash and equity incentive compensation.Stock ownership guidelines for directors and members of executive management.56 2024 Sustainable Business ReportOur People&Communities Total Rewards continued.to provide benchmarking against our peers within the industry.We review our compen

200、sation and ben-efi ts programs annually to ensure competitiveness within the marketplace.Job FrameworkIn 2023,we implemented a new job framework,which applies structure by categorizing and leveling our jobs based on job duties,responsibilities,qual-ifi cations,and expectations of each role,providing

201、 clarity for both employees and managers.The new job framework gives us the ability to market price every job and helps to ensure that compensation is fair and equitable across the organization.Tandem complies with new transparency legislation,and by implementing a new job framework and provid-ing p

202、ay transparency,we are creating an equitable workplace,providing clarity for career growth op-portunities,and building trust with our employees.Employee Assistance and WellnessOur employee assistance and wellness programs off er a range of benefi ts and services.For example,as a benefi t to our empl

203、oyees and their eligible dependents,we provide access to personal and job-related counseling and assis-tance resources for addressing concerns such as emotional well-being,family and relationships,legal and fi nancial mat-ters,healthy lifestyles,mental health,substance abuse,and work and life transi

204、tions.Mind and BodyBecause we emphasize a healthy body and mind,we provide a robust off ering of virtual and in-person wellness sessions and benefi ts.In 2023,we introduced a new employee wellness platform,FitOn,that now has nearly 1,000 registered users.Be YourselfDiversity among our team members m

205、akes our culture stronger and the products Tandem creates better.Together,we live our values.American Heart AssociationIn 2023,we received Silver recognition from the American Heart Association for our focus on internal collaboration to in-crease the reach of wellness within Tandem.This is a notable

206、 improvement following the Bronze recognition we received in 2022 for our implementation of quality workforce health and well-being programs and culture of health best practices.Tandem Diabetes Care 57Comprehensive,Relevant,Innovative Benefi ts+Health insurance +Paid time off +Paid and unpaid leaves

207、 +Retirement plan +Employee stock purchase plan +Health savings accounts +Flexible spending accounts +Life and disability coverage +Voluntary accident coverage +Voluntary critical illness coverage +Voluntary hospital indemnity coverage +Legal and identity theft coverage +Employee discount program +E

208、mployee loaner pump program +Voluntary pet insurance +Comprehensive employee assistance program +Travel assistance program 58 2024 Sustainable Business ReportOur People&Communities Community Outreach and Impact For many people with diabetes,peer support plays a key role in successful diabetes manage

209、ment.To help fulfi ll this need,we work with a broad spectrum of people and organizations pro-viding peer support and education through diabetes communi-ties and programs.Our employee community outreach eff orts include donations and volunteer work,serving on boards and advisory committees,and other

210、 corporate and individual actions.Examples of our corporate giving eff orts include:+Corporate support of diabetes scholarship programs in-cluding the Donnelly Awards and Diabetes Hope Foundation+Launch of Bright Funds Employee Giving&Volunteering platform,which provides employees a choice of where

211、they direct giving and volunteering time for causes of signifi cance to them +JDRF annual employee fundraising campaigns in support ofdiabetes research+Virtual Spanish Summit hosted by our community partners,JDRF and Beyond Type 1,designed to reach the Spanish-speaking type 1 diabetes population in

212、the United States +Diabetes camp partnerships with Camp Conrad Chinnock and Camp Kudzu that specifi cally support underserved communities and where our employees volunteerWe strive to be a good corporate citizen in the communities in which ouremployees live and work.Continued on next page.Tandem Dia

213、betes Care 59Tandem Diabetes Care at the JDRF One Walk.60 2024 Sustainable Business ReportCommunity Outreach and Impact continued.Community EventsWe also support and attend regional diabetes events hosted by various organizations in the United States and Canada:+American Diabetes Association+Childre

214、n with Diabetes+Connected in Motion+Diabetes Canada+Diabetes Education and Camping Services+iChallenge Diabetes+JDRF+JDRF Canada+PADRE Foundation+The DiaTribe Foundation+Taking Control of Your Diabetes Tandem Diabetes Care with Beyond Type 1 at the NYC Marathon.Tandem Diabetes Care 61Diabetes camps

215、encour-age,educate,and motivate children to live well with diabetes.DECA works on behalf of children with diabe-tes by providing leadership and support to all diabetes camps worldwide.The mission of Touched by Type 1 is to elevate awareness of and educate the community about the realities of living

216、with type 1 diabetes,raise funds to fi nd a cure,and inspire those with diabetes to thrive.A Canadian charity that creates a culture of support and engagement in diabetes self-management through peer-based experiential diabetes education,sport,and outdoor adventure.Through platforms,programs,resourc

217、es,and grants,Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today.The leading global organization funding type 1 diabetes(T1D)research to keep people healthy and safe until a cure for the disease is found.Riding on Insulin empowers,activates,and conn

218、ects the global diabetes community through shared experience and action sports.62 2024 Sustainable Business ReportOperating ResponsiblyWe are working to develop envi-ronmental programs that span our operations with the intent to conserve natural resources,reduce emissions,minimize waste,and prevent

219、pollution.Tandem Diabetes Care 6364 2024 Sustainable Business ReportOperating Responsibly Climate Change To achieve our objectives,we look to adopt innovative solutions for continual improvement in our operational and site management practices,as well as our working relationships with suppliers and

220、contractors.In 2024,we continue our road map for future emissions reduction strategies.We are working to understand domestic and international climate change topics,trends,and laws,as well as carbon emissions so that these may be factored into our near-and longer-term plans.Our initial eff orts will

221、 focus on the areas of our Company that we anticipate may have the greatest impact,including our manufacturing,supply chain,and facility operations.Gradually,we envision that all departments will contribute towards identifying our climate risks and opportunities.In 2023 we began working with third-p

222、arty advisors to develop a road map for calculating our greenhouse gas(GHG)emis-sions footprint.We anticipate that this continuing exercise will support future emissions reduction strategies and will also contribute to our understanding of our climate-related risks and opportunities.We continue to w

223、ork to understand do-mestic and international climate change topics,trends,and laws,as well as carbon emissions so that these may be fac-tored into our near-and longer-term plans.Our initial eff orts are focused on the areas of our Company that we anticipate may have the greatest impact,including ou

224、r manufacturing,supply chain,and facility operations.In 2024,our company goals once again include driving economic effi ciencies and process improvement with environmental impact in mind.Tandem Diabetes Care 65Energy ConsumptionWe aim to reduce our global energy consumption each year through continu

225、ed execution of energy conservation initiatives.We have dedicated eff orts toward reducing energy use in our lighting.We have actively pursued rebates from San Diego Gas&Electric to fund energy improvement projects,and our facilities use LED lighting,motion sensors,or both,to reduce energy consumpti

226、on.We are also working to reduce energy consumption for air conditioning and heating through occupancy scheduling.In the Spring of 2023,we began operating out of an about 144,000 square feet of additional general administrative,laboratory,and research and development offi ce space.This building is E

227、nergy Star certifi ed,and certifi ed under the U.S.Green Building Councils Leadership in Energy and Environmental Design(LEED).Energy use and environmental impact were key factors in the selection of our new facility.This facility features a solar-generating power system for our operations that are

228、currently located at four separate buildings,which resulted in more effi cient energy use and reduced consumption of resources.Total kWh20223,429,33320233,393,293kWh/Ft220221.0520230.84*Using square footage of Headquarters building and omitting Roselle buildings due to relocation during mid year.A c

229、orrection was made to the square footage calcula-tion used in the energy consumption metrics previously disclosed for 2022.Reducing Energy Use66 2024 Sustainable Business ReportOperating Responsibly Water Consumption While Tandem is not a signifi cant user of water,and our manufacturing processes ar

230、e not water intensive,we recognize the value of water as a limited and valuable natural resource.We are committed to acting in an environmentally responsible manner by maintaining and continually improving our sustainability and management systems,including water stewardship,to support our business

231、and the communities where we operate.Being headquartered in San Diego means the risk of drought and changing water quality exist,however,at this time,there is no anticipated substantive impact to our business.Still,we strive to conserve water consumption in our operations and use hands-free automati

232、c sink faucets and automatic toilet fl ush valves in all buildings.In 2022,we established a baseline for our water consumption that can be used can be used for future management and comparison.Waste ConsumptionTandem is focused on continual improvements to make in-cremental forward progress in creat

233、ing greater sustainability across our business.We have made concentrated eff orts to understand our waste consumption,which includes baselin-ing and monitoring our weight of waste,including non-haz-ardous,hazardous,biohazard,universal,and recycling.In 2023,we launched a new compost initiative for ou

234、r San Diego locations as part of our environmental program to reduce landfi ll waste.As a result,5,980 pounds(0.36%)was diverted from landfi lls in 2023.We aim to consistently analyze our processes that generate waste and look at ways to continually improve.For example,steps are taken at every HCF20

235、223,96220233,277Reducing Water UseTandem Diabetes Care 67CO2 saved from assets inventoried/resoldlbs134,000 possible stage to reduce the amount of waste and identify alternate methods of use or disposal to limit the impact on the environment.With this approach,weve had successes that range from redu

236、cing landfi ll waste by baling and recycling our cardboard,to putting a commingled recycling program in place.We are also taking steps to move toward a circular economy model for our products.An example of our circular economy com-mitment is our pump refurbishment program that reduces the impact of

237、our devices on the environment as discussed inthe“Impact Through Innovation”section of this report.Total U.S.Non-Hazardous Waste Recycling50%40%30%20%10%Landfi llCardboardMix RecyclingE-WasteCO2 emissions reducedToxic metals reduced144,000 lbs2,975lbs 2022 2023From our recycled E-Waste(2022 and 2023

238、 combined)Note:Landfi ll data(62%of waste recycled in 2022 vs.56%in 2023)is not comparable between 2022 and 2023.Landfi ll data for 2022 does not include waste generated from four buildings we previously occupied,as the data was not available.These buildings were consolidated into our new headquarte

239、rs beginning May 2023,and is included in our landfi ll waste reporting.68 2024 Sustainable Business ReportOperating Responsibly Supply Chain Our responsible sourcing philosophy is driven by our belief in doing business the right way.Thus,we are working to understand how our suppliers adhere to envir

240、onmental and social responsibility principles that align with those valued by Tandem.Strong partnerships with our strategic suppliers,including a shared commitment to leadership in sustainable practices,technology,and business operations,ensure we can provide high-quality and responsibly manufacture

241、d products to ourcustomers.We are mindful of the environmental impact of our supply chain eff orts.Our supplier agreements provide that products sold to us are manufactured in compliance with applicable national,provincial,state,and local environmental health and safety statutes,acts,ordinances,rule

242、s,codes,standards,andlaws.+We use sea freight for a majority of our international shipments,which has lower emissions than road or air+We use electronic forklift s and repeat pallet use in our warehouse operations +We receive annual confl ict mineral disclosures from oursuppliers We value partners w

243、ho are making commitments to reduce their environmental impact.+Omni,our third-party logistics provider,signed the Climate Pledge in the third quarter of 2021 committing to net zero carbon by 2040 +Convatec,our primary third-party infusion set manufactur-er,has set a goal to achieve net zero carbon

244、by 2045+Flex,our third-party contract manufacturer,made a commitment in the third quarter of 2022 to reach net zero greenhouse gas emissions by 2040We believe we have a responsibility to source our materials in a legal and ethical manner.As part of the Companys com-mitment to supply chain transparen

245、cy,and in compliance with the California Transparency in Supply Chains Act,we are transparent in our actions to prevent and address slavery and human traffi cking in our supply chain.Tandem Diabetes Care 69and address supplier risks.Preliminary risk assessments are performed by Tan-dem on potential

246、suppliers with Supplier Qualifi cation Surveys.Upon review of the survey,as determined appropriate,Tandem may follow up with an in-depth assessment,which may include assess-ing the risk related to the potential for slavery and human traffi cking.Audit In 2023,we developed new template supplier agree

247、ments obligating that all products sold to us comply with all codes,standards,and laws.Aft er a top-level supplier is approved,a Sup-plier Scorecard and ongoing Supplier Performance Evaluations are conduct-ed by the Supplier Management Team at scheduled intervals.The evaluations focus on quality man

248、agement system compliance and quality performance and are conducted by Tandem.Sup-pliers are required to follow Supplier Corrective Action Requests that out-linehow the supplier will resolve any issues uncovered in an evaluation.Accountability Tandem maintains and enforces internal accountability st

249、andards and procedures for employees through a Code of Business Conduct and Ethics for Employees and Directors.We work to hold suppliers and contract manufacturers accountable through contractual agreements.In the case of non-compliance or suspected non-compliance,Tandem reserves the right to review

250、 the specifi c situation and develop a best possible strategy for resolution.Tandem may terminate a business relationship if any such standards are not upheld.Agreements Our written supply agreements require a supplier to comply with all applicable laws.Training All Tandem employees are required to

251、comply with our Code of Business Conduct and Ethics.All Tandem em-ployees participate in annual training on the Companys Code to ensure un-derstanding and compliance with the requirements of the Code.This training includes ethical decision making and upholding laws and regulations.In ad-dition,Tande

252、m maintains a compliance program that conducts audits of certain requirements under the Code and other compliance policies,investigates po-tential violations,and takes disciplinary action when necessary.Assessment Tandem is working to engage in the verifi cation of its supplier and contract manufact

253、urer supply chain to evaluate As part of our eff ort to provide transparency,we conduct the following:70 2024 Sustainable Business ReportAppendix Tandem Diabetes Care 71The Sustainable Business Report for Tandem Diabetes Care was created to begin aligning our disclosures with the Sustainability Acco

254、unting Standards Board(SASB)Medical Equipment and Supplies Standards.All data presented is as of December 31,2023,unless otherwise noted.Contact:Please send any comments or questions about this report to IRSASB Medical Equipment and Supplies Sustainability Accounting StandardDisclosureLocation or Re

255、sponseAff ordability and Pricing HC-MS-240a.2Description of how price information for each prod-uct is disclosed to custom-ers or to their agentsThe t:slim X2 insulin pump and its supplies are typically reimbursed through customers Durable Medical Equipment insurance benefi t in the United States.Af

256、t er a new customer fi lls out a form to start the process of getting a t:slim X2 pump,a Tandem representative reaches out to their healthcare provider and insurance company(s)to help determine their benefi ts.When they are ready to order an insulin pump,our insurance verifi cation team will help th

257、e user through the process and work to get thelowest out-of-pocket cost.HC-MS-240a.3 Percentage change in:(1)weighted average list price and(2)weighted average net price across product portfolio compared to pre-vious reporting period.While reimbursements diff er by customer insurance plan,geography,

258、and product,Tandem discloses our estimated net pricing in our quarterly company overview.72 2024 Sustainable Business ReportDisclosureLocation or ResponseProduct Safety HC-MS-250a.1Number of recalls issued,total units recalledIn 2023,Tandem did not initiate any fi eld actions HC-MS-250a.2Products li

259、sted in any public medical product safety or adverse event alert databaseThe FDAs MedWatch Safety Alerts for Human Medical Products database has the following Tandem products that had at least one MedWatch Report submitted in 2023:HC-MS-250a.3Number of fatalities related to products as reported in t

260、he FDA Manufacturer and User Facility Device ExperienceThere were 28 MedWatch reports submitted by Tandem Diabetes Care in the calendar year 2023 associated with a death.Submission of a MedWatch report is not an admission that a product,user facility,importer,distributor,manufacturer,or medical pers

261、onnel caused or contributed to the event.HC-MS-250a.4Number of enforcement actions taken in response to violations of good manufacturing practices(GMP)or equivalent standards,by typeTandem had no warning letters,seizures,or injunctions issued in 2023+t:slim Insulin Pump+t:fl ex Insulin Pump +t:slim

262、G4 Insulin Pump +t:slim X2 Insulin Pump +t:slim X2 G5 Insulin Pump +t:slim X2 Pump with Basal-IQ Technology +t:slim X2 Pump with Control-IQ Technology +Tandem Mobi SystemTandem Diabetes Care 73DisclosureLocation or ResponseEthical Marketing HC-MS-270a.1 Total amount of monetary losses as a result of

263、 legal proceedings associated with false marketing claimsTandem had no monetary losses in 2023 as a result of legal proceedings associated with false marketing claims HC-MS-270a.2Description of code of eth-ics governing promotion of off -label use of productsTandem has an Interactions with Healthcar

264、e Providers(HCPs)Policy to ensure our communications,including any business meetings or trainings,with HCPs must be intended to train or educate HCPs only in a manner consistent with the FDA-cleared product labeling.Tandem also has a Patient Interactions Policy to ensure that our communications to p

265、atients and the public are truthful,not misleading,and that our employees do not engage in any off -label promotion with our patients or the public.Our Policies are post-ed on the Company intranet and apply to all employees so that they may understand their individual obligations to ensure that thei

266、r communications about Tandem products are truthful,not misleading,and consistent with the FDA-cleared product labeling and FDA and FTC regulations.Product Design and Lifecycle Management HC-MS-410a.1Discussion of process to as-sess and manage environ-mental and human health considerations associate

267、d with chemicals in products,and meet demand for sustainable productsSustainable Business Report 2023,Impact Through Innovation74 2024 Sustainable Business ReportDisclosureLocation or ResponseProduct Design and Lifecycle Management(continued)HC-MS-410a.2Total amount of products accepted for takeback

268、 and reused,recycled,or donated,broken down by:(1)devices and equipment and(2)suppliesIn 2023,Tandem refurbished approximately 55,000 t:slim X2 pumpsSupply Chain Management HC-MS-430a.1 Percentage of(1)entitys facilities and(2)Tier I suppliers facilities participating in third party audit programs f

269、or manufacturing and product quality100%for entitys facility and Tier 1 suppliersHC-MS-430a.2Description of eff orts to maintain traceability within the distribution chainAvailable through electronic device history records and proof of deliveryrecordsHC-MS-430a.3Description of the management of risk

270、s associated with the use of critical materialsControlled by procurement team with open purchase orders,quarterly business reviews,safety stock,alternate suppliers,and appropriate storage in warehouseTandem Diabetes Care 75DisclosureLocation or ResponseBusiness Ethics HC-MS-510a.1Total amount of mon

271、etary losses as a result of legal proceedings associated with bribery or corruptionTandem had no monetary losses in 2023 as a result of legal proceedings associated with bribery or corruptionHC-MS-510a.2Description of code of ethics governing interactions with healthcare professionalsTandem has an I

272、nteractions with Healthcare Providers(HCPs)Policy to ensure our collaborative relationships with HCPs meet high ethical stan-dards.Tandem adopts and adheres to the AdvaMed Code of Ethics,which is incorporated into our Policy by reference,though in certain instances Tandem policies and procedures are

273、 more restrictive than the guidelines set forth by AdvaMed.Our Policy is posted on the Company intranet and applies to all employees so that they may understand their individual obligations to act ethically and compliantly when interacting with HCPs.Activity Metric HC-MS-000.ANumber of units sold by

274、 product CategoryIn the four-year period,ended December 31,2023,we shipped approximately 450,000 insulin pumps,which is representative of our in-warranty global installed customer base assuming the typical four-year reimbursement cycleExcept where specifi cally noted otherwise,the reporting period o

275、f the Tandem 2023 Sustainable Business Report covers subject matter and data for the Tandem fiscal year ended December 31,2023 and is limited to the operations owned and/or operated by Tandem.References to Tandem,our,we,or the Company mean Tandem Diabetes Care,Inc.and its subsidiaries,unless the con

276、tent indicates otherwise.Data associated with the operations of acquisitions completed during or after the fi scal year are not included in the reported metrics,including the operations of Capillary Biomedical,LLC and AMF Medical SA.Goals,targets,intentions,ambitions,or expectations described in thi

277、s report,are aspirational and subject to change and are not guarantees or promises that all goals,targets,intentions,ambitions,or expectations will be met.There can be no assurance that our sustainability or ESG policies and procedures as described in this report will continue;such policies and proc

278、edures could change,even materially.We are permitted to determine in our discretion that it is not feasible or practical to implement or complete certain of our sustainability or ESG initiatives,policies,and procedures based on cost,timing,or other considerations.Safe Harbor Statement under the Priv

279、ate Securities Litigation Reform Act of 1995:Statements in this report that relate to future events,expectations,and trends involve factors that are subject to change and risks and uncertainties that could cause actual results to differ materially.These risks and uncertainties are diffi cult to pred

280、ict and often are outside of the control of the Company.When used in this report,the words“may,”“could,”“anticipate,”“target,”“plan,”“continue,”“goal,”“commit,”“achieve,”“project,”“intend,”“estimate,”“believe,”“expect,”and similar expressions are intended to identify forward-looking statements,altho

281、ugh not all forward-looking statements contain such words.Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or anticipated results.Forward-looking statements are n

282、either historical facts nor assurances of future performance.Instead,they are based only on the companys current beliefs,expectations,and assumptions regarding the future of its business,strategic objectives,projections,anticipated economic changes and trends,and other conditions.Forward-looking sta

283、tements in this report may include,but are not limited to,estimates of addressable market size statements regarding the Companys operational strategies;equipment designs that optimize performance outcomes for customers;efforts regarding energy,water,and emissions;and the development of mechanisms fo

284、r tracking sustainability metrics.Important factors that could cause the companys actual results to differ materially from those indicated in the forward-looking statements include,among others,the following:(i)compliance with and changes to global and regional environmental,health,safety,and human

285、rights laws,including emissions and noise regulations,and other ethical business practices;(ii)compliance with and changes to greenhouse gas emissions and other standards related to climate change;(iii)production,design,and technological innovations and diffi culties,including capacity and supply co

286、nstraints and prices;(iv)availability and price of raw materials,components,and whole goods;(v)attracting,developing,engaging,and retaining qualifi ed employees;(vi)weather conditions and natural calamities;(vii)availability of enabling technologies;(viii)network security breaches and disruptions;(i

287、x)compliance with privacy and data-protection laws and regulations;(x)global and regional trade laws,regulations,and policies;(xi)governmental banking,monetary,and fiscal policies;(xii)global tax laws;(xiii)demand for the companys products;(xiv)global political,economic,and social events and uncerta

288、inty;(xv)competitors actions and competitive pressures;(xvi)adapting products to customer preferences around the world;(xvii)infringement of the companys intellectual property;(xviii)economic conditions weakening demand and/or limiting access to funding and higher funding costs;(xix)ability to reali

289、ze the anticipated benefits of our business strategies including acquisitions,joint ventures,divestitures,or new product or effi ciency initiatives;(xx)public health threats;and(xxi)general global macroeconomic conditions,including but not limited to infl ation,slower growth or recession,higher inte

290、rest rates,and currency fl uctuations.The company,except as required by law,undertakes no obligation to update or revise any forward-looking statements,whether as a result of new developments or otherwise.The forward-looking statements speak only as of the date of this report,and undue reliance shou

291、ld not be placed on these statements.Certain information contained herein has been obtained from third parties,and in certain cases has not been updated through the date hereof.We have not independently verifi ed the data from these third-party sources in every instance and make no representation wi

292、th regard to the verifi cation of third-party data,unless explicitly otherwise indicated.While these third-party sources are believed to be reliable,we make no representation or warranty,express or implied,with respect to the accuracy,fairness,reasonableness,or completeness of any of the information

293、 contained herein,and we expressly disclaim any responsibility or liability therefor.The information contained herein is only as current as the date indicated and may be superseded by subsequent market events or for other reasons.Tandem is not under any obligation to update or keep current the infor

294、mation contained herein.Statistics and metrics relating to ESG matters are estimates and may be based on assumptions or developing standards.This report may contain links and references to other Internet sites.Such links or references are not endorsements of any products or services in such sites,an

295、d no information in such site has been endorsed or approved by the company.The inclusion of information in this report should not be construed as a characterization regarding the materiality or financial impact of that information.Further information concerning the company and its businesses,includi

296、ng factors that could materially affect the companys financial results,is included in the companys filings with the Securities and Exchange Commission(SEC)(including,but not limited to,the factors discussed in Item 1A,Risk Factors of the companys most recent annual report on Form 10-K,and quarterly

297、reports on Form 10-Q).Visit for important safety information about Tandem products.2024 Tandem Diabetes Care,Inc.All rights reserved.Tandem Diabetes Care,the Tandem logo,t:fl ex,t:slim,t:slim G4,t:slim X2,Basal-IQ,Control-IQ,t:connect,Tandem Mobi,and Tandem Source are either registered trademarks or

298、 trademarks of Tandem Diabetes Care,Inc.in the United States and/or other countries.The Bluetooth word mark and logos are registered trademarks owned by Bluetooth SIG,Inc.and any use of such marks by Tandem Diabetes Care is under license.Android is a trademark of Google LLC.All third-party marks are the property of their respective owners.CM-002750_B